Clinical Trials Directory

Trials / Completed

CompletedNCT00051246

Group Therapy for Postpartum Depression

Relational Group Intervention for Postpartum Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
147 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will compare standard individual treatment to group therapy for the treatment of postpartum depression.

Detailed description

Ten to twenty percent of new mothers experience major depression in the postpartum period or postpartum depression (PPD). This condition poses a risk for disturbances in the mother-infant relationship as well as for developmental delays and subsequent psychopathology in their children. Thus, and investigation of the efficacy of a relational approach that focuses on improving the mother's sense of competence in the parenting role, and reducing depressive symptoms and social isolation through group therapy is warranted. Patients are randomly assigned to either relational group treatment or to standard individual treatment. Assessments of maternal and infant functioning, mother-infant and father-infant relations, parenting stress, and marital conflict and conducted pre- and post-treatment, at 12 months post-treatment, and when infants are 12 and 24 months of age.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMother-Infant Group PsychotherapyMother-infant group psychotherapy consists of weekly 2.5-hour psychotherapy sessions comprised of mother's group therapy, infant developmental therapy, and mother-infant dyadic psychotherapy. Group treatment will last 15 weeks.
BEHAVIORALInterpersonal PsychotherapyIndividual psychotherapy treatment focuses on role transition, interpersonal relationships, and loss. Individual treatment period will last 15 weeks.

Timeline

Start date
2002-01-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2003-01-08
Last updated
2014-01-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00051246. Inclusion in this directory is not an endorsement.